Your browser doesn't support javascript.
loading
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature.
Lizzul, Laura; Lombardi, Giuseppe; Barbot, Mattia; Ceccato, Filippo; Gardiman, Marina Paola; Regazzo, Daniela; Bellu, Luisa; Mazza, Elena; Losa, Marco; Scaroni, Carla.
Afiliación
  • Lizzul L; Endocrinology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy.
  • Lombardi G; Neurooncology Unit, Venetian Oncologic Institute (IOV), 35121, Padua, Italy.
  • Barbot M; Endocrinology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy.
  • Ceccato F; Endocrinology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy.
  • Gardiman MP; Pathology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy.
  • Regazzo D; Endocrinology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy.
  • Bellu L; Neurooncology Unit, Venetian Oncologic Institute (IOV), 35121, Padua, Italy.
  • Mazza E; Department of Oncology and Pathology Unit, San Raffaele University Hospital, 20132, Milan, Italy.
  • Losa M; Pituitary Unit, Department of Neurosurgery, San Raffaele University Hospital, 20132, Milan, Italy.
  • Scaroni C; Endocrinology Unit, Department of Medicine (DIMED), Padua University Hospital, 35121, Padua, Italy. carla.scaroni@unipd.it.
Pituitary ; 23(4): 359-366, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32232709

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Carcinoma / Adenoma / Antineoplásicos Alquilantes / Temozolomida / Duración de la Terapia / Recurrencia Local de Neoplasia Tipo de estudio: Guideline País/Región como asunto: Europa Idioma: En Revista: Pituitary Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Carcinoma / Adenoma / Antineoplásicos Alquilantes / Temozolomida / Duración de la Terapia / Recurrencia Local de Neoplasia Tipo de estudio: Guideline País/Región como asunto: Europa Idioma: En Revista: Pituitary Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article